Patient characteristics and doses of growth hormone and glutamine
| Patient No | Age (y) | Sex | Duration of HPN (y) | Small bowel (cm) | Colon (%)1-150 | BMI (kg/cm2) | Diagnosis | Growth hormone (mg/kg/day) | Oral glutamine (g/day) | Parenteral glutamine (g/day) |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 33 | F | 11 | 100 | 86 | 22 | CD | 0.14 | 30 | 3.2 |
| 2 | 74 | M | 7 | 90 | 86 | 24 | MI | 0.09 | 29 | 4.1 |
| 3 | 42 | F | 5 | 100 | 43 | 19 | CD | 0.14 | 30 | 3.4 |
| 4 | 45 | F | 10 | 140 | 28 | 24 | CD | 0.07 | 30 | 4.0 |
| 5 | 47 | F | 11 | 150 | 0 | 25 | CD | 0.05 | 19 | 3.7 |
| 6 | 32 | F | 3 | 120 | 0 | 21 | CD | 0.14 | 29 | 8.5 |
| 7 | 49 | F | 8 | 100 | 0 | 24 | CD | 0.12 | 29 | 6.8 |
| 8 | 55 | F | 3 | 30 | 0 | 21 | MI | 0.14 | 30 | 8.0 |
M, male; F, female; BMI, body mass index; CD, Crohn's disease; MI, mesenteric infarction.
↵1-150 Per cent of remnant colon.8